Stockscreener 앱 받기
75.42
2.15%
1.59
시간 외 거래:
75.42
전일 마감가:
$73.83
열려 있는:
$74.51
하루 거래량:
436.73K
Relative Volume:
0.51
시가총액:
$4.14B
수익:
$1.39B
순이익/손실:
$-242.49M
주가수익비율:
-16.85
EPS:
-4.4759
순현금흐름:
$173.29M
1주 성능:
+3.43%
1개월 성능:
+17.48%
6개월 성능:
+18.14%
1년 성능:
+80.09%
1일 변동 폭
$70.74
$75.81
1주일 범위
$70.74
$75.81
52주 변동 폭
$41.02
$75.81
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
75.42 | 4.06B | 1.39B | -242.49M | 173.29M | -4.4759 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
LivaNova appoints Stefano Folli to lead its cardiopulmonary business unit - MSN
LivaNova names Stefano Folli as president, CP - Medical Buyer
Why (LIVN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
LIVN Technical Analysis & Stock Price Forecast - Intellectia AI
Paradice Investment Management LLC's LivaNova PLC(LIVN) Holding History - GuruFocus
LivaNova names Stefano Folli as cardiopulmonary president - Investing.com UK
LivaNova appoints Franco Poletti as President, Cardiopulmonary - TipRanks
LivaNova names Stefano Folli as cardiopulmonary president By Investing.com - Investing.com South Africa
LivaNova names Stefano Folli to head cardiopulmonary unit - StreetInsider
LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit - Business Wire
LivaNova PLC stock (US5356991077): cardiac device specialist in focus after regulatory update and ea - AD HOC NEWS
LivaNova’s SWOT analysis: medical device stock eyes growth plan By Investing.com - Investing.com Canada
LivaNova’s SWOT analysis: medical device stock eyes growth plan - Investing.com
LivaNova PLC Lifts 2026 Outlook After Strong Q1 - TipRanks
LivaNova stock hits 52-week high at 73.31 USD By Investing.com - Investing.com Australia
LivaNova stock hits 52-week high at 73.31 USD - Investing.com India
LivaNova to present at Goldman Sachs Global Healthcare Conference in June - MSN
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June 2026 - BioSpace
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June - Business Wire
Will LivaNova's (LIVN) Return to Quarterly Profitability Reset Investor Expectations on Its Turnaround Narrative? - simplywall.st
LivaNova PLC stock (US5356991077): cardiac device maker updates investors after latest earnings - AD HOC NEWS
Total debt per share of LivaNova Plc – SWB:LIA - TradingView
LivaNova PLCOrdinary Shares (NQ: LIVN - FinancialContent
Vagus Nerve Stimulators Market to Reach USD 1.86 Billion by 2033 - openPR.com
ETFs Investing in LivaNova Plc Stocks - TradingView
LivaNova stock (US5356991077): Medical device leader with Nasdaq listing - AD HOC NEWS
Understanding Momentum Shifts in (LIVN) - Stock Traders Daily
LivaNova (LIVN) Q3 2025 Earnings Transcript - AOL.com
LivaNova (LIVN) Stock Forum and Discussion - Moomoo
Drug Resistant Epilepsy Market to Reach US$ 1.28 Billion by 2033 - openPR.com
LivaNova stock hits 52-week high at 71.97 USD By Investing.com - Investing.com Nigeria
LivaNova PLC Lifts Guidance After Strong Q1 Call - TipRanks
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Why LivaNova (LIVN) Is Up 18.0% After Boosting 2026 Outlook And Winning Aura6000 FDA Approval - Yahoo Finance
LivaNova stock hits 52-week high at 71.97 USD - Investing.com India
LivaNova PLC 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LIVN) 2026-05-08 - Seeking Alpha
LivaNova PLC (LIVN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Active Implantable Medical Devices Market Size is Anticipated - openPR.com
LIVN Maintained by Baird -- Price Target Lowered to $76.00 - GuruFocus
LIVN Maintained by Mizuho -- Price Target Raised to $90.00 - GuruFocus
LivaNova (LIVN) Q1 2025 Earnings Transcript - AOL.com
Q1 2026 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC (NASDAQ:LIVN) Q1 2026 Earnings Call Transcript - Insider Monkey
LivaNova Q1 2026 slides: double-digit growth drives guidance raise By Investing.com - Investing.com Australia
LivaNova revenue up 14.3% to USD 362.3M in Q1 2026 - Medical Buyer
LivaNova: Q1 Earnings Snapshot - theheraldreview.com
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.27%
2.05%
자본화:
|
볼륨(24시간):